GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...

GSK’s dealmaking will be “cautious and disciplined” under the current trade war, but the pharma will focus on looking for ...

GSK stock jumped Wednesday after the British drugmaker said it's "well positioned" to respond if the U.S. levies tariffs on ...

GSK (GSK) stock gains as the company's Q1 2025 results beat Street forecasts thanks to its Specialty Medicines business. Read ...

GSK will use technologies including artificial intelligence to improve its productivity as a means of compensating for the potential financial hit from US tariffs on the pharmaceutical sector.

In its update, GSK reported a 17% rise in speciality medicines across its HIV, cancer and respiratory business to £2.93 ...

GSK posted higher profit as sales for its specialty treatments for HIV, cancer and asthma beat expectations, offsetting lower ...

British drugmaker GSK said during its first-quarter results on Wednesday, the firm was "well positioned" to respond to the ...

The FTSE 100 drugmaker said it was "well positioned" to tackle the impact of sector-specific tariffs as speculation mounts ...